Skip to main content

Assembly Biosciences, Inc.

ASMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001426800

No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Assembly Biosciences, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ASMB: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders75192+18
Shares13.6M849.3K18.7M+6.03M (+47.4%)
Value$376.4M$23.5M$514.8M+$161.9M (+45.9%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Assembly Biosciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ASMB in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC849,309$23.4M0.01%
Ameriprise Financial Inc230,000$6.32M0.00%
DV Equities, LLC226,415$6.22M0.90%
Standard Life Aberdeen plc207,047$5.69M0.01%
Affinity Asset Advisors, LLC190,000$5.22M0.26%
Squadron Capital Management LLC160,000$4.40M1.51%
Woodline Partners LP150,780$4.14M0.01%
Driehaus Capital Management LLC150,000$4.12M0.02%
Ally Bridge Group (NY) LLC140,000$3.85M4.96%
Franklin Resources Inc113,200$3.11M0.00%
Charles Schwab Investment Management Inc29,128$800.4K0.00%
Bank of New York Mellon Corp24,015$659.9K0.00%
Nuveen, LLC16,875$463.7K0.00%
Invesco Ltd.11,864$326.0K0.00%
Integrated Quantitative Investments LLC10,078$276.9K0.05%
Deutsche Bank AG9,615$264.2K0.00%
Wells Fargo & Company8,253$226.8K0.00%
Price T Rowe Associates Inc8,203$226.0K0.00%
Persistent Asset Partners Ltd6,942$190.8K0.06%
MetLife Investment Management5,885$161.7K0.00%
Mirae Asset Global ETFs Holdings Ltd.4,519$124.2K0.00%
New York State Common Retirement Fund4,200$115.4K0.00%
Police & Firemen's Retirement System of New Jersey2,907$79.9K0.00%
Legal & General Group Plc958$26.3K0.00%
Ameritas Investment Partners, Inc.895$24.6K0.00%
Russell Investments Group, Ltd.788$21.7K0.00%
HSBC Holdings PLC16,935$17.1K0.00%
Sterling Capital Management LLC199$5.47K0.00%
Truvestments Capital LLC193$5.30K0.00%
FMR LLC178$4.89K0.00%
California State Teachers Retirement System136$3.74K0.00%
Caitong International Asset Management Co., Ltd75$2.06K0.00%
Quarry LP75$2.06K0.00%

Sold out (15)

Institutions that held Assembly Biosciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ASMB in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Blackstone Group Inc.296,855$8.24M
Adage Capital Partners GP, L.L.C.161,000$4.47M
Patient Square Capital LP136,315$3.78M
Arrowstreet Capital, Limited Partnership39,446$1.09M
Jane Street Group, LLC34,499$957.3K
Susquehanna International Group, LLP32,949$914.3K
683 Capital Management, LLC27,863$773.2K
Wellington Management Group LLP26,496$735.3K
Federated Hermes, Inc.18,904$524.6K
Hudson Bay Capital Management LP16,799$466.2K
Jump Financial, LLC10,917$302.9K
Omers Administration Corp8,100$224.8K
Aquatic Capital Management LLC220$6.11K
US Bancorp59$1.64K
Fifth Third Bancorp57$1.58K

Not filed for Q2 2026 yet (1)

Institutions that held Assembly Biosciences, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASMB in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC849,309$23.5M